KFF Health News 53d ago

A federal court’s decision to override the FDA and restrict availability of the abortion pill mifepristone has launched abortion back into the national spotlight. It’s also raised new questions about the job security of FDA Commissioner Marty Makary. Sandhya Raman of Bloomberg Law, Shefali Luthra of The 19th, and Jessie Hellmann of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Andrew Jones, who wrote the latest “Bill of the Month,” about an emergency room bill for a visit that wasn’t an emergency — but could have been. Chapters: 00:00 - Introduction 00:57 - Abortion Pill Access 09:37 - Drug Industry Freak Out 11:48 - FDA OKs Fruit-Flavored Vapes 14:28 - Conflicting Messages on Fentanyl Testing Strips 15:37 - FDA Censors Vaccine Studies 17:07 - Another Surgeon General Nominee 20:31 - ACA Enrollment Expected to Drop 20% 23:06 - Downsides of US Leaving WHO 25:05 - RFK Jr. Wants Patients Off Antidepressants 28:11 - Bill of the Month 33:16 - Extra Credits